Dana Mendenhall

Dana Mendenhall is a seasoned executive with extensive experience in the pharmaceutical and medical device industries. Most recently, Dana served as Senior Vice President and Global Head of Commercial and Portfolio Strategy for Plasma Derived Therapies at Takeda Pharmaceuticals, focusing on global growth and commercialization strategies. Prior roles include Vice President of Marketing for BD, and Vice President of Marketing for the Renal Division at Baxter International Inc., where Dana led significant market transformations and commercial turnarounds. Additionally, Dana has a strong foundation in cross-functional roles at Ethicon, Inc. and holds an MBA from Northwestern University's Kellogg School of Management and a Bachelor's Degree in Industrial Engineering from Texas A&M University.